Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Part of paid clinical trials in Gilbert, Arizona.
- Sponsor
- Miltenyi Biomedicine GmbH
- Study ID
- NCT06116110
- Status
- Recruiting
Conditions
- Central Nervous System Lymphoma
- High Grade B-cell Lymphoma
- Non Hodgkin Lymphoma
- Primary Mediastinal B-cell Lymphoma (PMBCL)
- Refractory Diffuse Large B Cell Lymphoma (DLBCL)
- Relapsed Diffuse Large B Cell Lymphoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Long-term Follow-Up — OTHERNo intervention
Study Details
This is an observational long-term follow-up (LTFU) study for subjects who previously received zamtocabtagene autoleucel, known as MB-CART2019.1.
Key Dates
- First listed
- Nov 3, 2023
- Start date
- May 15, 2024
- Status verified
- Aug 2026
- Primary completion
- Dec 1, 2041
- Completion
- Dec 1, 2041
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Long-term Follow-UpNo intervention
Primary Outcome Measure
Number of subjects with new or recurrence of pre-existing malignancy [ Time Frame: Up to 15 years ]
Central Contacts
- Sadie Swift617-218-0044
- Paris Jamiel617-218-0044
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | Yasmin Adam |
| Stanford University | Stanford | California | 94305 | Christina Tran |
| Yale University | New Haven | Connecticut | 06520 | Jialing Zhang |
| Robert H Lurie Cancer Center | Chicago | Illinois | 60611 | Chiena Whitt Reem Karmali, MD (PRINCIPAL_INVESTIGATOR) |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | Sunil Abhyankar, MD |
| University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | Nancy Hardy, MD |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Christopher Simmons |
| Duke University Medical Center - Division of Hematologic Malignancies | Durham | North Carolina | 27705 | Matthew McKinney, MD |
| Oregon Health and Science University Knight Cancer Institute | Portland | Oregon | 97239 | Richard Maziarz, MD |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | Farrukh Awan, MD |
| Froedtert Hospital and the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Hailey McArthey |
Find similar trials in Gilbert, AZ
By research site
Related Studies
- Long-term Follow-up Study of Patients Receiving CAR-T CellsRecruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesPHASE1/PHASE2 · Recruiting · CellCentric Ltd. · Atlanta, Georgia
- CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell MalignanciesPHASE1/PHASE2 · Recruiting · Medical College of Wisconsin · Milwaukee, Wisconsin